Aspen Pharmacare (OTCMKTS:APNHY) Shares Gap Down - Should You Sell?

Key Points

• Shares of Aspen Pharmacare gapped down about 10.9%, opening at $7.89 from a $8.86 close, with only 458 shares traded—a sharp drop on very low volume.
• Despite the decline, the stock remains above its 50‑day ($7.50) and 200‑day ($6.31) moving averages, so longer‑term technical support has not been decisively broken.
• Aspen Pharmacare is a Durban‑based multinational pharmaceutical company whose ADRs trade OTC under the ticker APNHY, focusing on branded and generic injectable and oral medicines.

Shares of Aspen Pharmacare (OTCMKTS:APNHY - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $8.86, but opened at $7.89. Aspen Pharmacare shares last traded at $7.89, with a volume of 458 shares changing hands.

Aspen Pharmacare Stock Down 10.9%

The firm has a 50-day moving average of $7.50 and a two-hundred day moving average of $6.31. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.18.

Aspen Pharmacare Company Profile

Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.

Aspen's core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.